期刊文献+

雌激素对人脐静脉内皮细胞HSP27表达的影响 被引量:2

Effects of estrogen on the expression of HSP27 in human umbilical vein endothelial cells
下载PDF
导出
摘要 目的:观察人脐静脉内皮细胞(human umbilical vein endothelial cell,HUVEC)中热休克蛋白27(HSP27)表达在雌激素(estrogen,E)诱导下的改变。方法:分别用10–9 M、10–8 M、10–7 M雌二醇(estradiol,E2)以及10–6 M雌激素受体拮抗剂他莫昔芬(tamox ifen)处理HUVEC后,采用Western blot法和RT-PCR法检测HUVEC中HSP27蛋白和m RNA的表达水平。结果:与对照组相比,无论是蛋白水平还是m RNA水平,10–9 mol/L E2对HUVEC中HSP27表达没有明显影响;10–8、10–7 mol/L E2诱导HUVEC中HSP27表达逐渐增加(P<0.05);而HUVEC与10–6 M他莫昔芬、10–7 M雌二醇共同孵育,其HSP27水平和单纯10–7 M雌二醇处理相比明显减少(P<0.05)。结论:外源性E2能诱导HUVEC中HSP27的表达,呈剂量依赖性。他莫昔芬能阻断E2的这种上调HSP27的作用,提示雌激素诱导内皮细胞HSP27的表达依赖ER。 Objective: To investigate the change of the expression of HSP27 in human umbilical vein endothelial cells(HUVECs) induced by estrogen. Methods: After incubated with different concentrations of estradiol(10–9 mol/L, 10–8 mol/L, 10–7 mol/L, respectively) and 10–6 mol/L tamoxifen(an antagonist of estrogen receptor), the expression of HSP27 protein and m RNA in HUVEC were detected by Western blot and RT-PCR, respectively. Results: Compared with the control group, the expression of HSP27 m RNA and protein in HUVEC were significantly up-regulated by E2(P〈0.05)(10–8, 10–7 mol/L E2); however, the effect that estradiol increase the expression of HSP27 were inhibited obviously by 10–6 mol/L tamoxifen(P〈0.05). Conclusion: The expression of HSP27 in HUVEC was increased significantly by E2 in a dose-dependent manner. Tamoxifen can inhibit these effects of E2. The data of the studies suggested that the expression of HSP27 in endothelial cells that induced by estrogen is dependent on estrogen receptors.
出处 《临床与病理杂志》 CAS 2014年第5期520-524,共5页 Journal of Clinical and Pathological Research
基金 国家自然科学基金(81270360) 湖南省科技厅科技计划重点项目(2014FJ2012) 湖南省教育厅项目(11C1179) 湖南省郴州市科技局项目([2011]29) 湖南省重点建设学科(2011-76)~~
关键词 雌激素 人脐静脉内皮细胞 热休克蛋白27 estrogen human umbilical vein endothelial cells heat shock protein 27
  • 相关文献

同被引文献23

  • 1MARTIN-VENTURA J L, DURAN M C, BLANCO-COLIO L M, et al. Identiflcation by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis[J]. Circulation, 2004, 110(15): 2216-2219.
  • 2MILLER H, POON S, HIBBERT B, et al. Modulation of estrogen signaling by the novel interaction of heat shock protein 27, a biomarker for atherosclerosis, and estrogen receptor β[J]. Arterioscler Thromb Vasc Biol, 2005, 25(3): 10-14.
  • 3AL-MADHOUN A S, CHEN Y X, HAIDARI L, et al. The interaction and cellular localization of HSP27 and ERβ are modulated by 17β-estradiol and HSP27 phosphorylation[J]. Molecular and Cellular Endocrinology, 2007, 270(1/2): 33-42.
  • 4RAYNER K, SUN J F, CHEN Y X, et al. Heat Shock protein 27 protects against atherogenesis via an estrogen-dependent mechanism: role of selective estrogen receptor beta modulation[J]. Arteriosclerosis Thrombosis and Vascular Biology, 2009, 29(11): 1751-1756.
  • 5YUAN P, WU W H, GAO L, et al. Oestradiol ameliorates mono-crotaline pulmonary hypertension via NO, prostacyclin and endothelin-1 pathways[J]. Eur Respir J, 2013, 41(5): 1116-1125.
  • 6WATERS D D, GORDON D, ROSSOUW J E, et al. Women's ischemic syndrome evaluation: current status and future research directions. report of the national heart, lung and blood institute workshop: lessons from hormone replacement trials[J]. Circulation, 2004, 109(6): 53-55.
  • 7WILD R A, WU C,CURB J D, et al. Coronary heart disease events in the women's health initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women, Health Initiative randomized clinical trials[J]. Menopause, 2013, 20(3): 254-260.
  • 8LIND S L, LARS L, LANDBO T C, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial[J]. BMJ, 2012, 345(14): e6409.
  • 9MAKI P M, HENDERSON V W. Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on[J]. Climacteric, 2012, 15(3): 256-262.
  • 10KHALIL R A. Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease[J]. Biochem Pharmacol, 2013, 86(12): 1627-1642.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部